Description
Different energy sources are currently being used in clinics as physical agents for HCC nodule thermal ablation, either percutaneously or intraoperatively. Radiofrequency (RF) currents are the most commonly used, whereas microwave ablations (MWA) are gaining popularity. Thermal ablative treatments work by elevating the temperature of solid tumours above a deadly threshold (60 °C for rapid coagulative necrosis, 50 °C for extended heat exposure). Thermal ablation techniques provide a viable non-surgical treatment alternative for early-stage HCC in patients with well-compensated cirrhosis, thanks to their minimal invasiveness, excellent tolerability and safety profile, proven efficacy in local disease control, virtually unlimited repeatability, and cost-effectiveness.
When high-powered MWA treatments are used, there are many qualitative and quantitative variations in RFA:
During a thermal ablation operation, the hyper-echogenic patch surrounding the probe-active tip discernible on ultrasound-scanning forms and expands at a considerably faster pace, providing visual feedback of the ongoing vaporisation process;
Microwaves are generated by the needle in MWA to create a small area of heat. The heat kills the cancer cells in the liver. RFA and MWA are excellent therapy alternatives for patients who are unable to undergo surgery or whose tumours are less than 1.5 inches in diameter. Image guiding is used to send a needle through the skin into a liver tumour in radiofrequency ablation (RFA) and microwave ablation (MWA). RFA involves passing high-frequency electrical currents through an electrode in the needle, which heats up a tiny area.
Microwaves are generated by the needle in MWA to create a small area of heat. The heat kills the cancer cells in the liver. RFA and MWA are excellent therapy alternatives for patients who are unable to undergo surgery or whose tumours are less than 1.5 inches in diameter. Small liver tumours can be entirely removed with a success rate of more than 85%.
What is the procedure's mechanism?
Radiofrequency ablation uses electrical currents in the radiofrequency range to flow between the needle electrode and the grounding pads on the patient's skin. Heat is generated around the electrode as a result of these currents. The heat is sent into the tumour, where the cancer cells are heated and destroyed. Heat from radiofrequency energy also seals small blood vessels, reducing the risk of bleeding. Scar tissue progressively replaces the dead tumour cells, which diminishes over time.
Microwave ablation causes electromagnetic waves in the microwave energy spectrum to be produced. These microwaves generate heat around the needle, which causes the cancer cells to heat up and die. Heat constricts tiny blood vessels, reducing bleeding risk. Scar tissue gradually replaces the dying tumour cells.
To guide the needle electrode into the tumour, the clinician may employ ultrasound, computed tomography, or magnetic resonance imaging.
Benefits
In select patients whose liver tumours are inappropriate for surgical excision, radiofrequency and microwave ablation can be an effective treatment for primary liver cancer and cancers that have progressed to the liver.
More than half of liver cancers treated with ablation have not recurred in most studies. Small liver tumours can be entirely removed with a success rate of more than 85%.
Serious treatment-related problems are uncommon, and the discomfort is less than that of surgery.
Ablation can be used to treat recurring liver cancers on a regular basis.
Many kinds of liver cancer are treated using radiofrequency and microwave ablation. The following are the two most prevalent types:
Hepatocellular carcinoma is a type of liver cancer that starts in the liver cells (meaning it begins in the liver).
colon cancer that has progressed to the liver by metastasis.
Ablation can also be utilised to treat a variety of different cancers and tumours in the liver. Radiofrequency ablation is most effective in treating tumours with a diameter of less than one and a half inches. It can be used in conjunction with chemotherapy or radiation therapy, or it can be used instead of surgery.
SUBMIT YOUR BAND
Want airplay on Metal Devastation Radio, PR support through MDPR, or a shot at Tennessee Metal Devastation Music Fest?
Send your band name, location, and links (music + socials) to: zach@metaldevastationradio.com
We check every submission for radio rotation, PR campaigns, and live festival opportunities. If it fits, we’ll be in touch.

